Investors Home  >  Investor Relations
Briefcase Printed Materials Email Alerts Download Center snapshot RSS

Investor Relations

Ticker: CNAT
7.07 (+ 0.24)
Stock price graph

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Conatus Pharmaceuticals's financial performance into perspective.

Conatus Update

Sep 2, 2014
View Presentation

View all »   RSSRecent Releases

Oct 8, 2014
Conatus Pharmaceuticals Announces Acceptance of Late-Breaking Abstract for AASLD Annual Meeting

Oct 1, 2014
Conatus Pharmaceuticals Appoints David T. Hagerty as Executive Vice President, Clinical Development

View all »Events & Presentations

Sep 2, 2014
Conatus Update
PDF View Presentation   2.7 MB   Add to Briefcase

Aug 13, 2014
Conatus Pharmaceuticals Second Quarter 2014 Financial Results
Webcast Listen to webcast